Economic analysis of esophageal stenting for management of malignant dysphagia

Diseases of the Esophagus

Volumn 22, Issue 4, 2009, Pages 337-347

  Rao, C ^a   Haycock, A ^b   Zacharakis, E ^a   Krasopoulos, G ^a   Yakoub, D ^a   Protopapas, A ^a   Darzi, A ^a   Hanna, G B ^a   Athanasiou, Thanos ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Cost benefit analysis; Decision support techniques; Esophageal neoplasms; Palliative care

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER PALLIATIVE THERAPY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DISEASE SEVERITY; DYSPHAGIA; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MATERIALS TESTING; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; STENT;

CONFIDENCE INTERVALS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; PALLIATIVE CARE; PROBABILITY; QUALITY OF LIFE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STENTS;

EID: 65949087238     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00916.x     Document Type: Article

References (38)

1. Siersema P D, Hop W C, van B M et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: A prospective, randomized study. Gastrointest Endosc 2001; 54: 145-53.
2. McNamee P, Shenfine J, Bond J. Measuring quality of life and utilities in esophageal cancer. Expert Rev Pharmacoeconomics Outcomes Res 2003; 3: 179-88.
3. Knyrim K, Wagner H J, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 329: 1302-7.
4. Allum W H, Griffin S M, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut 2002; 50 (Suppl 5): v1-23.
5. Cancer Survival, England, 1999-2004. One- and Five-Year Survival of Patients Diagnosed 1999-2003 and Followed up to 2004: 21 Common Cancers, by Sex and Age. London: Office for National Statistics, 2005.
6. Earlam R, Cunha-Melo J R. Oesophageal squamous cell carcinoma: I. a critical review of surgery. Br J Surg 1980; 67: 381-90.
7. Muller J M, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
8. Roseveare C D, Patel P, Simmonds N, Goggin P M, Kimble J, Shepherd H A. Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: A randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. Eur J Gastroenterol Hepatol 1998; 10: 653-7.
9. O'Donnell C A, Fullarton G M, Watt E, Lennon K, Murray G D, Moss J G. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg 2002; 89: 985-92.
10. Kozarek R A, Ball T J, Brandabur J J et al. Expandable versus conventional esophageal prostheses: Easier insertion may not preclude subsequent stent-related problems. Gastrointest Endosc 1996; 43: 204-8.
11. Yakoub D, Fahmy R, Athanasiou T et al. Evidence-based choice of oesophageal stent in the palliative management of malignant dysphagia. World J Surg 2008; 32: 1996-2009.
12. Roseveare C D, Patel P, Simmonds N et al. Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: A randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. Eur J Gastroenterol Hepatol 1998; 10: 653-7.
13. Siersema P D, Hop W C, Dees J et al. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: A controlled, prospective study. Gastrointest Endosc 1998; 47: 113-20.
14. De Palma G D, di Matteo E, Romano G et al. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: A controlled prospective study. Gastrointest Endosc 1996; 43: 478-82.
15. Birch J F, White S A, Berry D P et al. A cost-benefit comparison of self-expanding metal stents and Atkinson tubes for the palliation of obstructing esophageal tumors. Dis Esophagus 1998; 11: 172-6.
16. Nicholson D A, Haycox A, Kay C L, Rate A, Attwood S, Bancewicz J. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy. Clin Radiol 1999; 54: 212-5.
17. Drummond M F, Sculpher M J, Torrance G W, O'Brien B J, Stoddart G L. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 2004.
18. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press, 2006.
19. Lubitz J, Cai L, Kramarow E, Lentzner H. Health, life expectancy, and health care spending among the elderly. NEJM 2003; 349: 1048-55.
20. Schousboe J T, Taylor B C, Fink H A et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 2007; 298: 629-37.
21. Lim S S, Gaziano T A, Gakidou E et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: Health effects and costs. Lancet 2007; 370: 2054-62.
22. Rao C, Aziz O, Panesar S S et al. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007; 334: 621-7.
23. National Institute for Health Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. London: NICE, 2004.
24. Roderick P, Davies R, Raferty J et al. The cost-effectiveness of screening for helicobacter pylori to reduce the mortality and morbidity from gastric cancer and peptic ulcer disease: A discrete-event simulation model. Health Technol Assess 2003; 7: 1-86.
25. Homs MY, Essink-Bot ML, Borsboom GJ, Steyerberg EW, Siersema PD, Dutch SIREC Study Group. Quality of life after palliative treatment for oesophageal carcinoma - a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 2004; 40: 1862-71.
26. Vij R, Triadafilopoulos G, Owens D K, Kunz P, Sanders G D. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 2004 (Nov); 60: 739-56.
27. The Department of Health. NHS Reference Costs 2006-7. London: The Department of Health, 2007. [Cited February 16, 2008.]Available from URL: http://www.dh.gov.uk/PolicyAndGuidance/OrganisationPolicy/ FinanceAndPlanning/NHSReferenceCosts/fs/en.
28. Blazeby J M, Williams M H, Brookes S T, Alderson D, Farndon J R. Quality of life measurement in patients with oesophageal cancer. Gut 1995 (Oct); 37 (4): 505-8.
29. Brunelli C, Mosconi P, Boeri P et al. Evaluation of quality of life in patients with malignant dysphagia. Tumori 2000; 86 (2): 134-8.
30. Loizou L A, Rampton D, Atkinson M, Robertson C, Bown S G. A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia. Cancer 1992 (Jul 15); 70(2): 386-91.
31. McLarty A J, Deschamps C, Trastek V F, Allen M S, Pairolero P C, Harmsen W S. Esophageal resection for cancer of the esophagus: Long-term function and quality of life. Ann Thorac Surg 1997 (Jun); 63 (6): 1568-72.
32. Blazeby J M, Alderson D, Winstone K et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer 1996 (Oct); 32A (11): 1912-17.
33. van Knippenberg F C, Out J J, Tilanus H W, Mud H J, Hop W C, Verhage F. Quality of Life in patients with resected oesophageal cancer. Soc Sci Med 1992; 35: 139-45.
34. Claxton K, Eggington S, Ginnelly L et al. A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence. CHE Research Paper 4. York: Centre for Health Economics, University of York, 2005.
35. Claxton K, Ginnelly L, Sculpher M, Philips Z, Palmer S. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Health Technol Assess 2004; 8: 31.
36. Yokota F, Thompson KM. Value of information literature analysis (voila): a review of applications in health risk management. Med Decis Making 2004; 24 (3): 287-98.
37. Rao C, Aziz O, Deeba S et al. Is minimally invasive harvesting of the great saphenous vein for coronary artery bypass surgery a cost-effective technique? J Thorac Cardiov Sur 2008; 135: 809-15.
38. Fenwick E, Claxton K, Sculpher M. The Value of Implementation and the Value of Information: Combined and Uneven Development. CHE Research Paper 5. York, UK: Centre for Health Economics, University of York, 2005.